Published in AJR Am J Roentgenol on March 01, 2005
Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy. Proc Natl Acad Sci U S A (2007) 3.27
Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging (2006) 2.69
Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol (2008) 2.52
Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment. Proc Natl Acad Sci U S A (2011) 1.62
Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques. Br J Cancer (2015) 1.43
Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy. Philos Trans A Math Phys Eng Sci (2011) 1.38
A nonrigid registration algorithm for longitudinal breast MR images and the analysis of breast tumor response. Magn Reson Imaging (2009) 1.23
Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. Eur Radiol (2010) 1.17
The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review. Insights Imaging (2013) 1.14
Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient. Acad Radiol (2010) 1.09
Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy. Br J Radiol (2010) 1.08
Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection? Eur Radiol (2006) 1.07
Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy. IEEE J Sel Top Quantum Electron (2011) 1.05
Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy. Cancer (2009) 1.00
Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy. Transl Oncol (2012) 1.00
Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer. Am J Surg (2010) 0.98
Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging. Radiology (2011) 0.97
The role of mammographic calcification in the neoadjuvant therapy of breast cancer imaging evaluation. PLoS One (2014) 0.97
Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer. Br J Cancer (2009) 0.95
Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results. Magn Reson Imaging (2013) 0.94
Validation of an algorithm for the nonrigid registration of longitudinal breast MR images using realistic phantoms. Med Phys (2010) 0.93
Diffuse optical tomography of the breast: preliminary findings of a new prototype and comparison with magnetic resonance imaging. Eur Radiol (2009) 0.92
Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile. Clin Breast Cancer (2012) 0.89
In vivo 1H MRS in the assessment of the therapeutic response of breast cancer patients. NMR Biomed (2011) 0.89
Early prediction of therapy responses and outcomes in breast cancer patients using quantitative ultrasound spectral texture. Oncotarget (2014) 0.89
Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL. Radiology (2015) 0.88
Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy. Breast Cancer (Dove Med Press) (2012) 0.87
Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology. J Surg Oncol (2013) 0.87
Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy. Br J Cancer (2013) 0.84
Neoadjuvant chemotherapy for breast cancer: correlation between the baseline MR imaging findings and responses to therapy. Eur Radiol (2010) 0.83
Treatment response assessment of breast masses on dynamic contrast-enhanced magnetic resonance scans using fuzzy c-means clustering and level set segmentation. Med Phys (2009) 0.83
Breast cancer spatial heterogeneity in near-infrared spectra and the prediction of neoadjuvant chemotherapy response. J Biomed Opt (2011) 0.82
Accuracy of perfusion MRI with high spatial but low temporal resolution to assess invasive breast cancer response to neoadjuvant chemotherapy: a retrospective study. BMC Cancer (2011) 0.81
Feasibility study of safe breast conservation in large and locally advanced cancers with use of radiopaque markers to mark pre-neoadjuvant chemotherapy tumor margins. World J Surg (2008) 0.80
Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy? Ann Surg Oncol (2015) 0.80
Molecular imaging using light-absorbing imaging agents and a clinical optical breast imaging system--a phantom study. Mol Imaging Biol (2011) 0.79
Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging. Cancer Res (2016) 0.79
Do Calcifications Seen on Mammography After Neoadjuvant Chemotherapy for Breast Cancer Always Need to Be Excised? Ann Surg Oncol (2017) 0.78
Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis. BMC Cancer (2015) 0.78
Which imaging modality is superior for prediction of response to neoadjuvant chemotherapy in patients with triple negative breast cancer? J Oncol (2013) 0.78
Palatal lesions: discriminative value of conventional MRI and diffusion weighted imaging. Br J Radiol (2016) 0.77
Normalization of compression-induced hemodynamics in patients responding to neoadjuvant chemotherapy monitored by dynamic tomographic optical breast imaging (DTOBI). Biomed Opt Express (2017) 0.77
Breast imaging in the young: the role of magnetic resonance imaging in breast cancer screening, diagnosis and follow-up. J Thorac Dis (2013) 0.77
Early prediction of response to neoadjuvant chemotherapy for locally advanced breast cancer using MRI. Nagoya J Med Sci (2011) 0.76
Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer. Br J Cancer (2013) 0.76
Morphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational study. Croat Med J (2016) 0.75
Current Status and Future Prospects of Proton MR Spectroscopy of the Breast with a 1.5T MR Unit. J Oncol (2010) 0.75
Trends and controversies in multidisciplinary care of the patient with breast cancer. Curr Probl Surg (2016) 0.75
FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies. Oncologist (2016) 0.75
Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL. Tomography (2016) 0.75
How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer. World J Clin Cases (2015) 0.75
Prediction of pathological complete response of breast cancer patients undergoing neoadjuvant chemotherapy: usefulness of breast MRI computer-aided detection. Br J Radiol (2014) 0.75
Effects of Neoadjuvant Chemotherapy on Benign Breast Lesions Compared to Cancers: Should an Additional Lesion on Magnetic Resonance Imaging Responding Similar to Cancer after Neoadjuvant Chemotherapy be Viewed with Suspicion? J Clin Imaging Sci (2016) 0.75
Neoadjuvant therapy for treatment of breast cancer: the way forward, or simply a convenient option for patients? Gland Surg (2017) 0.75
The effect of chemotherapy on the mammographic appearance of breast cancer and correlation with histopathology. Br J Radiol (2015) 0.75
Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands. BMC Cancer (2016) 0.75
Magnetic resonance imaging features of breast cancer according to intrinsic subtypes: correlations with neoadjuvant chemotherapy effects. Springerplus (2014) 0.75
Early prediction of pathological outcomes to neoadjuvant chemotherapy in breast cancer patients using automated breast ultrasound. Chin J Cancer Res (2016) 0.75
Chemotherapeutic drug-specific alteration of microvascular blood flow in murine breast cancer as measured by diffuse correlation spectroscopy. Biomed Opt Express (2016) 0.75
Performance of Mid-Treatment Breast Ultrasound and Axillary Ultrasound in Predicting Response to Neoadjuvant Chemotherapy by Breast Cancer Subtype. Oncologist (2017) 0.75
Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer. Breast Cancer Res (2016) 0.75
Breast conservation surgery: state of the art. Int J Breast Cancer (2011) 0.75
Collagen quantification in breast tissue using a 12-wavelength near infrared spectral tomography (NIRST) system. Biomed Opt Express (2017) 0.75
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature (2009) 18.08
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet (2010) 10.97
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature (2011) 9.71
A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science (2002) 9.59
The genome sequence of taurine cattle: a window to ruminant biology and evolution. Science (2009) 8.23
Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N Engl J Med (2011) 7.35
Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer (2003) 4.47
Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell (2012) 4.41
Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. J Clin Oncol (2012) 4.33
A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened. Cancer (2013) 4.21
Tomographic mammography using a limited number of low-dose cone-beam projection images. Med Phys (2003) 3.70
A comparison of reconstruction algorithms for breast tomosynthesis. Med Phys (2004) 3.41
Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes. Genome Res (2011) 2.94
NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw (2009) 2.78
Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging (2012) 2.72
Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda. AIDS (2003) 2.60
Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. J Infect Dis (2011) 2.44
Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling. J Pathol (2013) 2.35
Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. Int J Radiat Oncol Biol Phys (2009) 2.27
Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers. J Pathol (2011) 2.27
Mammography screening is saving thousands of lives, but will it survive medical malpractice? Radiology (2004) 2.24
Is excisional biopsy required after a breast core biopsy yields lobular neoplasia? AJR Am J Roentgenol (2012) 2.11
Practice parameters for colon cancer. Dis Colon Rectum (2004) 2.07
Enhanced imaging of microcalcifications in digital breast tomosynthesis through improved image-reconstruction algorithms. Med Phys (2009) 2.02
Outpatient falls prevention program outcome: an increase, a plateau, and a decrease in incident reports. AJR Am J Roentgenol (2014) 2.02
Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study. J Clin Oncol (2003) 1.96
Collateral vessels on CT angiography predict outcome in acute ischemic stroke. Stroke (2009) 1.94
Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol (2011) 1.93
Who needs a blood culture? A prospectively derived and validated prediction rule. J Emerg Med (2008) 1.91
Coregistered tomographic x-ray and optical breast imaging: initial results. J Biomed Opt (2005) 1.89
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood (2013) 1.84
Measurement of collagen and smooth muscle cell content in atherosclerotic plaques using polarization-sensitive optical coherence tomography. J Am Coll Cardiol (2007) 1.82
Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. Cancer Res (2010) 1.79
Combined optical and X-ray tomosynthesis breast imaging. Radiology (2010) 1.76
Combined optical imaging and mammography of the healthy breast: optical contrast derived from breast structure and compression. IEEE Trans Med Imaging (2009) 1.76
Retention among North American HIV-infected persons in clinical care, 2000-2008. J Acquir Immune Defic Syndr (2013) 1.73
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr (2013) 1.72
Relationship of pulmonary artery catheter use to mortality and resource utilization in patients with severe sepsis. Crit Care Med (2003) 1.72
Tomographic optical breast imaging guided by three-dimensional mammography. Appl Opt (2003) 1.69
A salmonid EST genomic study: genes, duplications, phylogeny and microarrays. BMC Genomics (2008) 1.68
Mammographic screening: patterns of use and estimated impact on breast carcinoma survival. Cancer (2004) 1.66
Characterization of atherosclerotic plaques by laser speckle imaging. Circulation (2005) 1.66
DNA hypomethylation within specific transposable element families associates with tissue-specific enhancer landscape. Nat Genet (2013) 1.64
Sepsis plasma protein profiling with immunodepletion, three-dimensional liquid chromatography tandem mass spectrometry, and spectrum counting. J Proteome Res (2006) 1.61
Genome comparison of barley and maize smut fungi reveals targeted loss of RNA silencing components and species-specific presence of transposable elements. Plant Cell (2012) 1.61
Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study. BMC Cancer (2008) 1.58
Survival in patients with brain metastases from breast cancer: the importance of HER-2 status. Cancer (2008) 1.57
Patient-provider communication differs for black compared to white HIV-infected patients. AIDS Behav (2011) 1.56
A conifer genomics resource of 200,000 spruce (Picea spp.) ESTs and 6,464 high-quality, sequence-finished full-length cDNAs for Sitka spruce (Picea sitchensis). BMC Genomics (2008) 1.55
SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing. J Natl Cancer Inst (2011) 1.53
Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum (2005) 1.52
Blinded comparison of computer-aided detection with human second reading in screening mammography. AJR Am J Roentgenol (2007) 1.51
Differentiation of HIV-associated lymphoma from HIV-associated reactive adenopathy using quantitative FDG PET and symmetry. Eur J Nucl Med Mol Imaging (2014) 1.51
Update on imaging of the postsurgical breast. Radiographics (2014) 1.49
Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: clinical implications. J Clin Oncol (2005) 1.48
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007. Breast J (2009) 1.48
Draft genome of the mountain pine beetle, Dendroctonus ponderosae Hopkins, a major forest pest. Genome Biol (2013) 1.46
Mutations in EZH2 cause Weaver syndrome. Am J Hum Genet (2011) 1.46
Radiotherapy for invasive breast cancer in North America and Europe: results of a survey. Int J Radiat Oncol Biol Phys (2005) 1.45
Differences in patient-provider communication for Hispanic compared to non-Hispanic white patients in HIV care. J Gen Intern Med (2010) 1.43
Case records of the Massachusetts General Hospital. Case 24-2005. A 58-year-old woman with early-stage estrogen-receptor-positive breast cancer. N Engl J Med (2005) 1.40
Mammography: yet another challenge. Radiology (2009) 1.39
The effect of tumor size and lymph node status on breast carcinoma lethality. Cancer (2003) 1.39
Not so fast: the use of incomplete data to devalue the role of mammography screening. Breast Cancer Res Treat (2012) 1.39
Characterization of experimental equine glanders. Microbes Infect (2003) 1.37
Kidney function and the risk of cardiovascular events in HIV-1-infected patients. AIDS (2010) 1.37
Transcription activator-like effector hybrids for conditional control and rewiring of chromosomal transgene expression. Sci Rep (2012) 1.37
Nonfunctionalized nanocrystals can exploit a cell's active transport machinery delivering them to specific nuclear and cytoplasmic compartments. Nano Lett (2007) 1.37
Gene expression profiles differentiate between sterile SIRS and early sepsis. Ann Surg (2007) 1.35
Mammographic breast density and race. AJR Am J Roentgenol (2007) 1.35
Predicting the survival of patients with breast carcinoma using tumor size. Cancer (2002) 1.34
Functional DNA methylation differences between tissues, cell types, and across individuals discovered using the M&M algorithm. Genome Res (2013) 1.33
Assembly and validation of the genome of the nonmodel basal angiosperm Amborella. Science (2013) 1.31
Salmo salar and Esox lucius full-length cDNA sequences reveal changes in evolutionary pressures on a post-tetraploidization genome. BMC Genomics (2010) 1.30
Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue. Breast J (2005) 1.28
VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy. Clin Cancer Res (2008) 1.27
Computer-aided detection system for breast masses on digital tomosynthesis mammograms: preliminary experience. Radiology (2005) 1.26
Severe sepsis: variation in resource and therapeutic modality use among academic centers. Crit Care (2003) 1.24
Efficient human pose estimation from single depth images. IEEE Trans Pattern Anal Mach Intell (2013) 1.22
Flare response in 18F-fluoride ion PET bone scanning. AJR Am J Roentgenol (2006) 1.21
Automated algorithm for differentiation of human breast tissue using low coherence interferometry for fine needle aspiration biopsy guidance. J Biomed Opt (2008) 1.21
Analysis of the mammographic and sonographic features of pseudoangiomatous stromal hyperplasia. AJR Am J Roentgenol (2008) 1.20
Low-dose CT of the abdomen: evaluation of image improvement with use of noise reduction filters pilot study. Radiology (2003) 1.20
Voting strategy for artifact reduction in digital breast tomosynthesis. Med Phys (2006) 1.20
Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study. Radiology (2003) 1.19
Compression-induced changes in the physiological state of the breast as observed through frequency domain photon migration measurements. J Biomed Opt (2007) 1.18
SNP discovery in black cottonwood (Populus trichocarpa) by population transcriptome resequencing. Mol Ecol Resour (2011) 1.18
In vivo proton magnetic resonance spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain. BMC Neurosci (2009) 1.16
Computer-aided detection of masses in digital tomosynthesis mammography: comparison of three approaches. Med Phys (2008) 1.16
The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma. Blood (2013) 1.15
Ultrasound as a complement to mammography and breast examination to characterize breast masses. Ultrasound Med Biol (2002) 1.15
Digital breast tomosynthesis: a better mammogram. Radiology (2013) 1.15
Pilot study of a web-based antibiotic decision management guide. J Am Coll Surg (2006) 1.13
Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging--Markov Monte Carlo decision analysis. Radiology (2008) 1.13